DTIL
Precision BioSciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.47
+1.36%Margins
Gross margin
100.0%
EBITDA margin
-111.1%
EBIT margin
-80.8%
Net margin
-117.0%
FCF margin
-115.3%
-116.4%
Return on equity
-41.9%
Return on assets
-49.6%
Return on invested capital
0.33x
Asset turnover
-$51.9M
Cash from operations
$3.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026